Hovione

Hovione and Firstgene Announce Strategic Collaboration

Exclusive licensing and R&D collaboration between Hovione and Firstgene.

Hovione Expands Spray Drying Capacities in the USA and Ireland

Lisbon, Portugal-headquartered Hovione has completed significant expansions in Europe and the USA. The investments at the facilities in East Windsor, New Jersey, and Ringaskiddy, Cork, significantly increase the global capacities of the CDMO (contract development and manufacturing organization) for spray drying for pharma applications and improve the sites' capabilities.

Hovione Expands Continuous Manufacturing Capabilities

Portuguese CDMO Hovione has expanded its continuous manufacturing capabilities with the start-up of a new facility at Loures. The company said it can now offer customers a commercial continuous tableting platform to support their key needs.

Expert Interview: Jean-Luc Herbeaux, Hovione

So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has uncovered problems that have been smoldering beneath the surface and need to be addressed. That supply chains are vulnerable to disruption when major development, production and transportation hubs are blocked or shut down has become painfully obvious.

Hovione Appoints Jean-Luc Herbeaux as Chief Operating Officer

Jean-Luc Herbeaux has been appointed as Chief Operating Officer (COO) of Hovione, effective May 1, 2020.

Asian Interest in European Chemical Companies

East or West? East and West!

Hovione to Sell iMAX Business, Reports Site Inspections

Hovione, Solvias Announce Collaborate on Improved Drug Solubility

Hovione Expands Particle Design Solutions to Solve Bioavailability

Hovione Appoints Mike Ironside as General Manager TTC

Hovione Announces Appointment of Dr. Conrad Winters as Drug Product Development Director

Hovione's Sales Grow 24%

Hovione Announces Appointment of Colin Minchom as Vice President, Particle Design Business Unit

Colin Minchom Appointed VP Particle Design BU at Hovione

The EFCG is Pushing Its Agenda Forward During Complex Times

Hovione Wins Flumethasone Patent Case

Hovione’s Sales Grow 15% in FY 2010

Hovione Scientists Bring PAT and Inhalation Expertise To USP